NCT01735201 - AGN-199201 for the Treatment of Erythema With Rosacea | Biotech Hunter

Enrollment

357

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

June 30, 2013

Conditions

RosaceaErythema

Interventions

DRUG

AGN-199201 Dose A

AGN-199201 Dose A applied once or twice daily to the face for 28 days.

DRUG

AGN-199201 Dose B

AGN-199201 Dose B applied once or twice daily to the face for 28 days.

DRUG

AGN-199201 Dose C

AGN-199201 Dose C applied once or twice daily to the face for 28 days.

DRUG

AGN-199201 Vehicle

AGN-199201 Vehicle applied once or twice daily to the face for 28 days.

Trial Locations (1)

Austin